Trehalose Designated Orphan Drug for ALS
SLS-005 contains the active ingredient trehalose, a low molecular weight disaccharide that crosses the blood brain barrier, stabilizes proteins and activates autophagy.
Amyotrophic Lateral Sclerosis
FDA Grants Fast Track Status to Arimoclomol for ALS
The FDA has granted Fast Track designation to arimoclomol (Orphazyme A/S) for the treatment of amyotrophic lateral sclerosis.
Insights Into the Diagnosis and Management of Amyotrophic Lateral Sclerosis
A diagnosis of amyotrophic lateral sclerosis can be overlooked by clinicians unfamiliar with the various signs of the disease.
FDA Grants Orphan Designation to Reldesemtiv for ALS
The FDA has granted Orphan Drug designation to reldesemtiv (Cytokinetics) for the treatment of amyotrophic lateral sclerosis.
ALS Treatment Approved for Use Via Percutaneous Endoscopic Gastrostomy Tube
The FDA has approved the supplemental New Drug Application for riluzole oral suspension to include administration via percutaneous endoscopic gastrostomy (PEG) tubes for the treatment of ALS.
Study Investigating Acthar Gel in the Treatment of ALS Discontinued
Mallinckrodt has permanently discontinued the phase 2b PENNANT trial investigating Acthar Gel (repository corticotrophin) for the treatment of amyotrophic lateral sclerosis.
AAN: Professional Soccer Players Show Increased Risk for ALS
Professional soccer players may have an increased risk for amyotrophic lateral sclerosis.
Tiglutik Now Available for the Treatment of Amyotrophic Lateral Sclerosis
Tiglutik is supplied as a thickened riluzole liquid that is intended to ease administration for patients with dysphagia.
FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis
The FDA approval was supported by data from bioavailability studies comparing riluzole tablets and Tiglutik oral suspension.
Rasagiline Plus Riluzole is Safe, May Improve Survival in ALS
Rasagiline was associated with a significant effect on survival within 6 months of treatment in an exploratory analysis.
-
Loading...
-
Loading...
Next post in Movement Disorders
